acel acquisit consist
strategi maintain neutral op execut
net dbt
acel acquisit play core strength
may announc acquisit acel medic technolog
compani focus advanc wound care gener revenu
adjust ebitda acquisit price ebitda net
synergi deal expect close previous estim could
deploy could add ep think
key synergi would leverag exist scale portfolio
relationship hospit gpo group purchas organ increas bulk
purchas achiev synergi sg take advantag acel extens
distribut outsid hospit grow medic consum presenc deal
long-term strateg posit expand higher growth return health
busi obviou synergi core technolog distribut expertis
maintain neutral recommend given limit oper visibl
ep accret year
forecast deal gener acel sale base cost
synergi year estim cost synergi come
streamlin sale sell cost repres lion share compani
sg sale also note like direct synergi opportun relat
manufactur outsid therapi devic consum specialti surgic
advanc wound dress product share servic estim deal
neutral slightli neg ep year accret year
physic integr standpoint think acel fairli straightforward
manufactur facil workforc repres total believ
integr acel direct salesforc key synergi goal
share buy-back outlook lower
expect financ acquisit mix exist cash new debt given
compani strong profil annual acquisit still leav liquid
continu share repurchas adjust share repurchas rang
estim pro forma acquisit
leverag step net debt/ebitda vs current estimate
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price
object basis/risk page
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
compani found mine
concern today minnesota-bas compani
diversifi global manufactur busi
technology-driven organ five
segment consum safeti graphic
electron health industri
popular brand includ scotch post-it
thinsul hold us patent
top line headwind well
telegraph compani reflect
portfolio mix unclear drive
margin declin compani
get back track margin expans
view core issu disrupt company-
wide erp roll-out schedul continu
least anoth year see limit
opportun near-term improv
chart revenu break-out segment
headquart san antonio tx acel medic technolog compani focus
advanc wound care specialti surgic applic busi would
complement medic consum busi group part compani
health busi health segment expect gener revenu
total oper margin vs corpor
averag medic consum repres health sale
exhibit complementari advanc wound care offer brand
global advanc wound care market worth around largest
sub segment neg pressur wound therapi npwt foam dress
biolog remain compris antimicrobi
geograph us largest market repres global
total close follow europ develop market tend
grow similar rate around rest world faster grow market worth
roughli grow
chart advanc wound care market sub segment
chart estim split awc market region-u remain
advanc wound care market estim grow compound-annual-growth-rate
acel focus three main product line npwt sale specialti surgic
advanc wound dress awd acel gener
revenu grow y/i overal organ busi oper
acel employe larg sale organ sale
profession us acel direct sale medic profession
countri includ us canada western europ japan indirect sale
third parti distributor anoth countri intern compani
direct sale employe distribut partner compani
manufactur facil one belgium one ireland
chart acel revenu segment
chart acel revenu region
npwt product line consist therapi devic dress acceler
wound heal process patient suffer acut chronic wound
diabet foot ulcer latest advanc dress includ
enabl instil wound cleans solut conjunct npwt acel
also develop technolog monitor deliveri npwt patient home
busi grew y/i acel share npwt market
compani estim global market opportun npwt
specialti surgic product line consist product market prevena
abthera brand acut care set prevena product use neg
pressur manag close surgic incis protect incis contamin
also remov fluid infecti materi reduc complic surgeri
abthera temporari abdomin closur system manag patient open
abdomen busi grew y/i address market
awd product line includ dress across categori includ collagen
super-absorb foam gell fiber contact layer line often use
use npwt specialti surgic product global awd market
exhibit acel product technolog
sinc acel undergon signific strateg transform includ
divest sever non-cor busi make acquisit focu wound care
transform also includ creat new market specialti surgic product
establish medic educ program build commerci team creat
awar drive demand acel appoint new ceo cfo sinc
invest innov product develop acceler rate product
launch success launch across segment meaning acceler
organ growth compani also made product improv achiev
cost save includ sell uk manufactur facil outsourc
forecast deal gener acel sale base cost
synergi year estim cost synergi come
streamlin sale sell cost repres lion share compani
sg sale also note like direct synergi opportun relat
manufactur outsid therapi devic consum specialti surgic
advanc wound dress product share servic indic
estim deal neutral slightli neg ep year
accret year physic integr standpoint think acel fairli
straightforward manufactur facil workforc repres
total believ integr acel direct salesforc
key synergi goal
po base price-to-earnings line multi-industri
peer trade discount premium consum compar
translat ev/ebitda believ in-lin valuat industri peer
warrant given lower growth outlook choppier execut still superior
return capit
po
note estim calendar decemb year end
ge ev calcul assign neg valu ge capit ge ebitda margin reflect industri busi
po base price-to-earnings line multi-industri
peer trade discount premium consum compar
translat ev/ebitda believ in-lin valuat industri peer
warrant given lower growth outlook choppier execut still superior
return capit
downsid risk po compani larg global emerg market
exposur need greater invest could margin headwind slower-than-
anticip global econom recoveri pfa litig impact
andrew obin herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
us multi-industrials/engin construct coverag cluster
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
